&w=3840&q=100)
This smallcap household appliances share price rises 2% today; check why
At 12:16 PM, Johnson Controls-Hitachi Air Conditioning India share price continued to trade higher, up 1.55 per cent at ₹1,770.85 per share. In comparison, BSE Sensex was trading 0.22 per cent higher at 83,590.54 levels.
What triggered the sharp up move in the stock price?
Johnson Controls-Hitachi Air Conditioning India rose today after the board declared an interim dividend of ₹36 per equity share (360 per cent) of ₹10 each for the year 2025-26.
The record date, meanwhile, for the purpose of determining the members eligible to receive the interim dividend for the financial year 2025-26, has been fixed as July 9, 2025.
The interim dividend will be paid on or before July 24, 2025, the company said.
Johnson Controls-Hitachi Air Conditioning India Q4 results
Johnson Controls-Hitachi Air Conditioning India reported a 14.87 per cent year-on-year (Y-o-Y) increase in net profit to ₹56.07 crore for the quarter ended March 2025 (Q4FY25), compared to ₹48.81 crore in the same quarter of the previous year (Q4FY24).
Revenue for the quarter also saw strong growth, rising 20.83 per cent to ₹932.57 crore from ₹771.81 crore in March 2024.
For the full financial year ended March 2025, the company posted a net profit of ₹58.83 crore, a major turnaround from a net loss of ₹75.71 crore in the previous fiscal year. Annual sales surged 43.66 per cent to ₹2,756.46 crore, up from ₹1,918.70 crore in FY24.
About Johnson Controls-Hitachi Air Conditioning India
Johnson Controls-Hitachi Air Conditioning was formed on October 1, 2015, as a joint venture between Hitachi Appliances, Inc. (now Hitachi Global Life Solutions, Inc.) and Johnson Controls, Inc.
As part of the agreement, Hitachi carved out its air conditioning business and contributed it to the new entity. Johnson Controls acquired a 60 per cent stake in this business, while Hitachi Global Life Solutions retained a 40 per cent share.
The partnership brings together two legacy companies, each with over a century of innovation and expertise, to create a dynamic new organisation. Together, they offer one of the industry's most comprehensive and diverse air conditioning product portfolios, delivering enhanced value to customers worldwide.
Johnson Controls-Hitachi Air Conditioning's market capitalisation is ₹4,815.1 crore, according to BSE.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
3 hours ago
- Business Standard
INR gains further ground at around 1-month high
The Indian rupee appreciated 16 paise to close at an over one-month high of 85.39 (provisional) against the US dollar on Friday, tracking a decline in the American currency in the overseas market and a weak tone in crude oil prices. Besides, rupee alongside other Asian currencies, gained ground on renewed hopes of trade deals with the US. US President Donald Trump announced a trade agreement with Vietnam, and that injected a dose of optimism that perhaps more such agreements could be in the pipeline before the crucial July 9 deadline. Meanwhile, the benchmark 30-share BSE Sensex ended the session up 193.42 points, or 0.23 percent, at 83,432.89, after having hit a low of 83,015.83 during intraday trade. The broader NSE Nifty index fell to 25,331.65 before reversing course to close up 55.70 points, or 0.22 percent, at 25,461 on optimism about India's upcoming trade deal with the United States.
Business Standard
4 hours ago
- Business Standard
Lupin launches generic version of anticholinergic medication Ipratropium bromide in United States
Lupin has announced the launch of Ipratropium Bromide Nasal Solution (nasal spray) in two strengths in the United States. Ipratropium Bromide Nasal Solution is a bioequivalent to Atrovent Nasal Sprayof Boehringer Ingelheim Pharmaceuticals, Inc. The solution is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis in adults and children aged 6 years and older. According to IQVIA MAT May 2025, Ipratropium Bromide Nasal Solution (RLD Atrovent) had estimated annual sales of $63 million in the U.S. Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. The companys consolidated net profit surged 114.9% to Rs 772.52 crore on a 13.6% jump in net sales to Rs 5,562.20 crore in Q4 FY25 over Q4 FY24. The scrip added 1.36% to end at Rs 1982.20 on the BSE today.
Mint
5 hours ago
- Mint
Small-cap stock under ₹50 hits 52-week high logging intraday gain of 14%. Do you own?
Small-cap stock under ₹ 50: Sindhu Trade Links share price jumped as much as 14 per cent, hitting 52-week on Friday, July 4. The small-cap stock opened at ₹ 30.22 apiece in the early morning session, as compared to previous close of ₹ 29.95. Sindhu Trade Links share price ascended over 31 per cent in past five trading sessions and over 54 per cent in a month. The small-cap stock has given significant returns of up to 65 per cent in last one year. Sindhu Trade's net sales declined to ₹ 134.22 crore in March 2025, a decrease of 7.61% compared to ₹ 145.27 crore in March 2024. The company reported a net loss of ₹ 7.31 crore in March 2025, a sharp drop of 140.51% from a profit of ₹ 18.03 crore in the same quarter last year. EBITDA fell significantly to ₹ 1.89 crore in March 2025, down 93.61% from ₹ 29.59 crore recorded in March 2024. The stock rallied amid rising market sentiments on Friday. India's benchmark indices Sensex and Nifty opened slightly higher on Friday, despite lingering uncertainty surrounding U.S. President Donald Trump's trade deal deadline scheduled for next week. The BSE Sensex rose by 53 points, or 0.06%, to reach 83,291, while the Nifty50 advanced 10 points, or 0.04%, to 25,415 in early trade. Among the Sensex constituents, Bajaj Finance, BEL, Bajaj Finserv, HUL, and HDFC Bank opened on a positive note, gaining as much as 2.2%. In contrast, Trent, Tech Mahindra, Tata Steel, and M&M registered losses. "There are no triggers to break the 25200-25800 Nifty range immediately. Even while trading within this range the market is resilient. This resilience is supported externally by the strength of the mother market US where S&P 500 and Nasdaq are at record highs and domestically by the strong and sustained flows into the market, which has made DIIs sustained buyers in the market. The cap to the upside of the range is put by the tepid earnings growth and expectations of modest earnings growth in FY26. Investors should watch for possible changes in the earnings growth trajectory, the indications of which will be available in the Q1 results, which will start coming soon. Outperformances in results are likely to be company-specific rather than sector-specific. For instance autos are likely to report modest numbers, but TVS, Eicher and M&M can deliver better than industry numbers. Similarly in financials Bajaj Finance and Sriram Finance may outperform. Therefore, market action is likely to be stock-specific," said VK Vijayakumar, Chief Investment Strategist, Geojit Investments Limited.
